China’s first and only weight-loss formulation of semaglutide for injection has been approved for the treatment of metabolic-associated steatohepatiti

S

ScienceDriven

Explorer
Joined
Sep 9, 2026
Messages
10
Reaction score
0
Location
Los Angeles, CA
China’s first and only weight-loss formulation of semaglutide for injection has been approved for the treatment of metabolic-associated steatohepatiti

Does the approval, which does not cover fatty liver disease indications, indicate that the technical review has been completed and the product is improving? Going forward, we’ll be able to use it wherever we go.
 
Back
Top